Clinical trial Recruiting at 1 site Observational Ages 18 to 75 Women only

EndoBreast: Feasibility and outcomes of nipple-sparing endoscopic mastectomy with immediate reconstruction

Official title: EndoBreast Study - Assessment of Feasibility, Functional Outcomes, and Sensitivity of the Areola-Nipple Complex in Endoscopic Mastectomy

Run by Azienda Sanitaria Locale Biella · NCT07718425 · Data updated 2026-11-12

This observational study tests whether endoscopic nipple-sparing mastectomy with immediate reconstruction is feasible and acceptable for women at risk or with breast cancer.

More Breast Cancer trials

Quick facts

Study typeObservational
Ages18 Years to 75 Years
SexWomen only
Enrollment30 (estimated)
SponsorAzienda Sanitaria Locale Biella
Government
Locations1 site (Ponderano, BI)
StatusRecruiting
StartedJune 23, 2026
Main results expectedJune 30, 2031
Study endsJune 30, 2031
Registry record updatedJuly 22, 2026
Trial IDNCT07718425 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are women aged 18–75 undergoing prophylactic or therapeutic nipple-sparing mastectomy with immediate implant-based reconstruction and suitable breast volume.

Probably not a fit

Patients with inflammatory breast cancer, prior breast cancer surgery or radiotherapy to the affected breast, or BMI >35 kg/m² may have less relevance or benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, single-center, non-interventional study conducted in routine clinical practice. Consecutive eligible women undergoing endoscopic nipple-sparing mastectomy with immediate reconstruction are enrolled to observe feasibility, functional outcomes of the areola-nipple complex, and patient satisfaction. No experimental treatments or changes to standard care are planned. The study aims to describe how well the procedure preserves NAC function and aesthetics in a real-world setting.

Why it matters

Potential benefit: If successful, the study could support the safety and practicality of endoscopic NAC-sparing mastectomy with immediate reconstruction, potentially improving cosmetic results and patient satisfaction.

How similar studies have gone: Previous reports suggest potential cosmetic and psychosocial benefits of NAC preservation, but robust comparative evidence for endoscopic approaches remains limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Female; age 18-75 years;
* indication for prophylactic or therapeutic NSM;
* breast volume suitable for endoscopic surgery;
* Regnault ptosis ≤ Grade II;
* eligibility for immediate implant-based reconstruction;
* WHO/ECOG performance status \<3;
* written informed consent.

Exclusion Criteria:

* Inflammatory breast cancer or skin involvement;
* previous breast cancer surgery or radiotherapy to the affected breast;
* BMI \>35 kg/m²; active smoking; ASA Physical Status \>2;
* pregnancy or breastfeeding;
* inability to provide informed consent;
* participation in incompatible interventional clinical trials.

Where it's running

  • Ospedale degli Infermi ASL BI
    Ponderano, Bi, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.